SCHEMBL3398713

SCHEMBL3398713

Cc1ccc(-n2c(Cn3cnc4c(NCc5ccccc5)ncnc43)nc3cccc(C)c3c2=O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 4/20 0.67
PIK3R1 P27986 2/20 0.67
PIK3CB P42338 1/20 0.57
PIK3CG P48736 1/20 0.57
TMIGD3 P0DMS9 2/20 0.48
ADORA2A P29274 2/20 0.48
ADORA1 P30542 2/20 0.48
RAB9A P51151 3/20 0.48
NPC1 O15118 2/20 0.48
HPGD P15428 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
GALR3 O60755 1/20 0.45
NR2F2 P24468 1/20 0.45
CDK1 P06493 3/20 0.45
CTSL P07711 1/20 0.45
CCNB2 O95067 1/20 0.43
CCNB1 P14635 1/20 0.43
CDK2 P24941 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL734026 0.90 PIK3CD (0.71) PIK3CDPIK3R1PIK3CBPIK3CGTMIGD3
SCHEMBL733252 0.88 PIK3CD (0.68) PIK3CDPIK3R1PIK3CBPIK3CGPDE4A
SCHEMBL733537 0.81 PIK3CD (0.68) PIK3CDPIK3R1PIK3CBPIK3CG
SCHEMBL733251 0.79 PIK3CD (0.77) PIK3CDPIK3R1PIK3CBPIK3CGPDE4A
SCHEMBL17185514 0.78 PIK3CD (0.73) PIK3CDPIK3R1PIK3CBPIK3CG
SCHEMBL3399490 0.75 PIK3CD (0.64) PIK3CDPIK3R1PIK3CBPIK3CG
SCHEMBL4160767 0.75 PIK3CD (0.73) PIK3CDPIK3R1PIK3CBPIK3CGADORA2A
SCHEMBL17806409 0.73 PIK3CD (0.60) PIK3CDPIK3R1PIK3CBPIK3CGTMIGD3
SCHEMBL360745 0.73 PIK3CD (1.00) PIK3CDPIK3R1PIK3CBPIK3CG
SCHEMBL29358478 0.73 PIK3CD (1.00) PIK3CDPIK3R1PIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8653077-B2 Inhibitors of human phosphatidylinositol 3-kinase delta ICOS CORPORATION (US) 2014-02-18 US disclosed
US-8492389-B2 Inhibitors of human phosphatidylinositol 3-kinase delta ICOS CORPORATION (US) 2013-07-23 US disclosed
US-20120135994-A1 INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2012-05-31 US disclosed
US-20100152211-A1 INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA ICOS CORPORATION 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152211-A1 INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA PIK3CD, PIK3CA, PIK3CG PIK3CD 1/4885PIK3R1 12/4885PIK3CB 4/4885
US-20120135994-A1 INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA PIK3CD, PIK3CA, PIK3CG PIK3CD 1/4885PIK3R1 12/4885PIK3CB 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.